Tackling Rising Drug Costs in the US: Is ERP an Option? Rising drug prices in the US are hot topic. Inbeeo takes a look at the recent drug pricing proposal by the Democrats suggesting the use of ERP. Read More »
4 Take-Away Messages From The Zolgensma® Pricing Storm Was the reaction to the $2.15m Zolgensma list price a tropical cyclone or more of a storm in a teacup? Read More »
Decoding the data: Analytics of Drug Pricing Tweets Inbeeo’s analysis of 2018 drug pricing tweets using NLP machine learning techniques highlight how emotive the issue of pharmaceutical pricing really is. Read More »